Cargando…

The Efficacy of Trastuzumab in Animal Models of Breast Cancer: A Systematic Review and Meta-Analysis

BACKGROUND: Breast cancer is the most frequent cancers and is the second leading cause of cancer death among women. Trastuzumab is an effective treatment, the first monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2). To inform the development of other effective...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Jiarong, Yang, Canhong, Guo, Bin, Sena, Emily S., Macleod, Malcolm R., Yuan, Yawei, Hirst, Theodore C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4963137/ https://www.ncbi.nlm.nih.gov/pubmed/27463246 http://dx.doi.org/10.1371/journal.pone.0158240

Ejemplares similares

Using median survival in meta-analysis of experimental time-to-event data
por: Hirst, Theodore C., et al.
Publicado: (2021)

Systematic Review and Meta-Analysis of the Efficacy of Interleukin-1 Receptor Antagonist in Animal Models of Stroke: an Update
por: McCann, Sarah K., et al.
Publicado: (2016)

A systematic review and meta-analysis of topoisomerase inhibition in pre-clinical glioma models
por: Jue, Toni Rose, et al.
Publicado: (2018)

Systematic review and meta-analysis of temozolomide in animal models of glioma: was clinical efficacy predicted?
por: Hirst, T C, et al.
Publicado: (2013)

Systematic review and stratified meta-analysis of the efficacy of RhoA and Rho kinase inhibitors in animal models of ischaemic stroke
por: Vesterinen, Hanna M, et al.
Publicado: (2013)

Systematic Review and Meta-Analysis of Therapeutic Hypothermia in Animal Models of Spinal Cord Injury
por: Batchelor, Peter E., et al.
Publicado: (2013)

Study protocol – A systematic review and meta‐analysis of hypothermia in experimental traumatic brain injury: Why have promising animal studies not been replicated in pragmatic clinical trials?
por: Hirst, Theodore C., et al.
Publicado: (2016)

Stem Cell Transplantation in Traumatic Spinal Cord Injury: A Systematic Review and Meta-Analysis of Animal Studies
por: Antonic, Ana, et al.
Publicado: (2013)

Publication Bias in Reports of Animal Stroke Studies Leads to Major Overstatement of Efficacy
por: Sena, Emily S., et al.
Publicado: (2010)

Improving our understanding of the in vivo modelling of psychotic disorders: A protocol for a systematic review and meta‐analysis
por: Bahor, Zsanett, et al.
Publicado: (2017)

Making the most of animal data – improving the prospect of success in pragmatic trials in the neurosciences
por: Egan, Kieren J, et al.
Publicado: (2011)

A systematic review and meta‐analysis of gene therapy in animal models of cerebral glioma: why did promise not translate to human therapy?
por: Hirst, T. C., et al.
Publicado: (2014)

Trastuzumab uptake and its relation to efficacy in an animal model of HER2-positive breast cancer brain metastasis
por: Lewis Phillips, Gail D., et al.
Publicado: (2017)

Lapatinib and lapatinib plus trastuzumab therapy versus trastuzumab therapy for HER2 positive breast cancer patients: an updated systematic review and meta-analysis
por: Yuan, Ye, et al.
Publicado: (2022)

Determinants of the Efficacy of Cardiac Ischemic Preconditioning: A Systematic Review and Meta-Analysis of Animal Studies
por: Wever, Kimberley E., et al.
Publicado: (2015)

Designing, conducting, and reporting reproducible animal experiments
por: Wilson, Emma, et al.
Publicado: (2023)

Systematic reviews and meta-analysis of preclinical studies: why perform them and how to appraise them critically
por: Sena, Emily S, et al.
Publicado: (2014)

Animal models of chemotherapy-induced peripheral neuropathy: A machine-assisted systematic review and meta-analysis
por: Currie, Gillian L., et al.
Publicado: (2019)

Efficacy, safety and administration timing of trastuzumab in human epidermal growth factor receptor 2 positive breast cancer patients: A meta-analysis
por: CHEN, YUAN-YUAN, et al.
Publicado: (2016)

The Automated Systematic Search Deduplicator (ASySD): a rapid, open-source, interoperable tool to remove duplicate citations in biomedical systematic reviews
por: Hair, Kaitlyn, et al.
Publicado: (2023)

Can Animal Models of Disease Reliably Inform Human Studies?
por: van der Worp, H. Bart, et al.
Publicado: (2010)

Efficacy and safety of lapatinib and trastuzumab for HER2-positive breast cancer: a systematic review and meta-analysis of randomised controlled trials
por: Xu, Zhi-qiao, et al.
Publicado: (2017)

Pertuzumab combined with trastuzumab compared to trastuzumab in the treatment of HER2-positive breast cancer: A systematic review and meta-analysis of randomized controlled trials
por: Liu, Xiaoyun, et al.
Publicado: (2022)

Risk of hepatotoxicity with trastuzumab emtansine in breast cancer patients: a systematic review and meta-analysis
por: Cobert, Amani M., et al.
Publicado: (2020)

Use of trastuzumab in treating breast cancer during pregnancy: a systematic review and meta-analysis
por: Xia, Lin-Yu, et al.
Publicado: (2021)

Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases
por: Kabraji, Sheheryar, et al.
Publicado: (2023)

Efficacy and safety of trastuzumab deruxtecan in the treatment of HER2-low/positive advanced breast cancer: a single-arm meta-analysis
por: Li, Zongyu, et al.
Publicado: (2023)

Efficacy and cardiac safety of the concurrent use of trastuzumab and anthracycline-based neoadjuvant chemotherapy for HER2-positive breast cancer: a systematic review and meta-analysis
por: Wu, Yu-Tuan, et al.
Publicado: (2018)

Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis
por: Han, Yiqun, et al.
Publicado: (2019)

Trastuzumab deruxtecan for breast cancer
Publicado: (2022)

Methodological quality evaluation of systematic reviews or meta-analysis of trastuzumab-based therapy for breast cancer: A systematic review
por: Wei, Hua, et al.
Publicado: (2021)

Trastuzumab immunogenicity development in patients’ sera and in laboratory animals
por: Kilany, Lobna Abdel Aziz, et al.
Publicado: (2021)

UCP-2 inhibitor enhanced the efficacy of trastuzumab against HER2 positive breast cancer cells
por: Hua, Jun, et al.
Publicado: (2021)

A randomised controlled trial of an Intervention to Improve Compliance with the ARRIVE guidelines (IICARus)
por: Hair, Kaitlyn, et al.
Publicado: (2019)

Efficacy and safety of short course adjuvant trastuzumab combination chemotherapy in breast cancer
por: Hingmire, Sachin S., et al.
Publicado: (2017)

6 versus 12 months of adjuvant trastuzumab in HER2+ early breast cancer: A systematic review and meta-analysis
por: Wang, Bi-Cheng, et al.
Publicado: (2021)

Effectiveness of trastuzumab as adjuvant therapy in patients with early stage breast cancer: A systematic review and meta-analysis
por: Davari, Majid, et al.
Publicado: (2017)

Systematic Review on the Use of Biosimilars of Trastuzumab in HER2+ Breast Cancer
por: Triantafyllidi, Eleni, et al.
Publicado: (2022)

Alpha Calcitonin Gene-Related Peptide Increases Cerebral Vessel Diameter in Animal Models of Subarachnoid Hemorrhage: A Systematic Review and Meta-analysis
por: Flynn, Liam M. C., et al.
Publicado: (2017)

Risk factors of trastuzumab-induced cardiotoxicity in breast cancer: A meta-analysis
por: Jawa, Zeeshan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4edpspg4o0qms541nvvlu34ec0